Literature DB >> 32248812

Household presentation of acute gastroenteritis in a primary care sentinel network: retrospective database studies.

Simon de Lusignan1,2,3, Julian Sherlock4,5, Filipa Ferreira4,5, Sarah O'Brien6, Mark Joy4,5.   

Abstract

BACKGROUND: Acute gastroenteritis (AGE) is a highly transmissible condition spreading rapidly between individuals and within households. Rotavirus vaccination was introduced in the UK in 2013. The study objectives were to investigate how acute gastroenteritis incidence changed over 25 years and household incidence of AGE since 2013.
METHODS: Repeated cross-sectional study of Royal College of General Practitioners Research and Surveillance Centre network. We used a negative binomial model to report incidence rate ratio (IRR) using the last 5 years data. We also conducted a retrospective cohort analysis, using a shared gamma frailty model (2013-2017). We explored the impact of child under 5- years, household size, socioeconomic status quintile, and rurality.
RESULTS: In the cross-sectional analysis, the IRR of AGE in households with a child of under 5 years was 12.20 (95%CI 11.08-13.45-, p < 0.001) compared with households without; the IRR fell across IMD quintiles, for example there is a 37% decrease in incidence comparing IMD quintile 1 to quintile 5 (95%CI -0.52-0.76, p < 0.001), The cohort study revealed that the presence of an under 5 in the household was associated with a higher risk of household presentation (HR = 6.29, 95% CI 5.61-7.06, p < 0.001). In addition, we observe a reduction in risk of presentation from the most to the least deprived socioeconomic quintile (second quintile: HR = 0.74 (95%CI 0.59-0.92), to least deprived quintile, HR = 0.55 (95%CI 0.41-0.74). We saw a lower association with male gender, white ethnicity and living outside London, but an increased association with increasing household size.
CONCLUSIONS: The incidence of AGE has changed over time: pre-school children, larger households, and living in London were associated with higher rates, and male gender and higher economic status associated with lower rates.

Entities:  

Keywords:  Computerised; Disease incidence; Family characteristics; Gastroenteritis; Infectious; Medical record systems; Population characteristics

Year:  2020        PMID: 32248812     DOI: 10.1186/s12889-020-08525-8

Source DB:  PubMed          Journal:  BMC Public Health        ISSN: 1471-2458            Impact factor:   3.295


  6 in total

1.  Risk Factors for Acute Gastroenteritis Among Patients Hospitalized in 5 Veterans Affairs Medical Centers, 2016-2019.

Authors:  Neha Balachandran; Jordan Cates; Anita K Kambhampati; Vincent C Marconi; Alexis Whitmire; Elena Morales; Sheldon T Brown; Diki Lama; Maria C Rodriguez-Barradas; Rosalba Gomez Moronez; Gilberto Rivera Domiguez; David O Beenhouwer; Aleksandra Poteshkina; Zlatko Anthony Matolek; Mark Holodniy; Cynthia Lucero-Obusan; Madhuri Agarwal; Cristina Cardemil; Umesh Parashar; Sara A Mirza
Journal:  Open Forum Infect Dis       Date:  2022-07-25       Impact factor: 4.423

2.  Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study.

Authors:  Simon de Lusignan; Jienchi Dorward; Ana Correa; Nicholas Jones; Oluwafunmi Akinyemi; Gayatri Amirthalingam; Nick Andrews; Rachel Byford; Gavin Dabrera; Alex Elliot; Joanna Ellis; Filipa Ferreira; Jamie Lopez Bernal; Cecilia Okusi; Mary Ramsay; Julian Sherlock; Gillian Smith; John Williams; Gary Howsam; Maria Zambon; Mark Joy; F D Richard Hobbs
Journal:  Lancet Infect Dis       Date:  2020-05-15       Impact factor: 25.071

3.  Excess mortality in the first COVID pandemic peak: cross-sectional analyses of the impact of age, sex, ethnicity, household size, and long-term conditions in people of known SARS-CoV-2 status in England.

Authors:  Mark Joy; Fd Richard Hobbs; Jamie Lopez Bernal; Julian Sherlock; Gayatri Amirthalingam; Dylan McGagh; Oluwafunmi Akinyemi; Rachel Byford; Gavin Dabrera; Jienchi Dorward; Joanna Ellis; Filipa Ferreira; Nicholas Jones; Jason Oke; Cecilia Okusi; Brian D Nicholson; Mary Ramsay; James P Sheppard; Mary Sinnathamby; Maria Zambon; Gary Howsam; John Williams; Simon de Lusignan
Journal:  Br J Gen Pract       Date:  2020-11-26       Impact factor: 5.386

4.  Investigating the uptake, effectiveness and safety of COVID-19 vaccines: protocol for an observational study using linked UK national data.

Authors:  Eleftheria Vasileiou; Ting Shi; Steven Kerr; Chris Robertson; Mark Joy; Ruby Tsang; Dylan McGagh; John Williams; Richard Hobbs; Simon de Lusignan; Declan Bradley; Dermot OReilly; Siobhan Murphy; Antony Chuter; Jillian Beggs; David Ford; Chris Orton; Ashley Akbari; Stuart Bedston; Gareth Davies; Lucy J Griffiths; Rowena Griffiths; Emily Lowthian; Jane Lyons; Ronan A Lyons; Laura North; Malorie Perry; Fatemeh Torabi; James Pickett; Jim McMenamin; Colin McCowan; Utkarsh Agrawal; Rachael Wood; Sarah Jane Stock; Emily Moore; Paul Henery; Colin R Simpson; Aziz Sheikh
Journal:  BMJ Open       Date:  2022-02-14       Impact factor: 3.006

5.  Mortality from angiotensin-converting enzyme-inhibitors and angiotensin receptor blockers in people infected with COVID-19: a cohort study of 3.7 million people.

Authors:  Hajira Dambha-Miller; William Hinton; Christopher R Wilcox; Agnieszka Lemanska; Mark Joy; Michael Feher; Beth Stuart; Simon de Lusignan; Julia Hippisley-Cox; Simon Griffin
Journal:  Fam Pract       Date:  2022-08-25       Impact factor: 2.290

6.  Disparities in the excess risk of mortality in the first wave of COVID-19: Cross sectional study of the English sentinel network.

Authors:  Simon de Lusignan; Mark Joy; Jason Oke; Dylan McGagh; Brian Nicholson; James Sheppard; Oluwafunmi Akinyemi; Gayatri Amirthalingam; Kevin Brown; Rachel Byford; Gavin Dabrera; Else Krajenbrink; Harshana Liyanage; Jamie LopezBernal; Cecilia Okusi; Mary Ramsay; Julian Sherlock; Mary Sinnathamby; Ruby S M Tsang; Victoria Tzortziou Brown; John Williams; Maria Zambon; Filipa Ferreira; Gary Howsam; F D Richard Hobbs
Journal:  J Infect       Date:  2020-08-25       Impact factor: 6.072

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.